These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4306072)

  • 1. [Effect of culture methods on the biological activities of Bordetella pertussis].
    Hirayanagi F
    Nihon Saikingaku Zasshi; 1969 Jan; 24(1):8-14. PubMed ID: 4306072
    [No Abstract]   [Full Text] [Related]  

  • 2. The relevance of agglutinogenic types of Bordetella pertussis in the assay of pertussis vaccines.
    Cameron J
    Prog Immunobiol Stand; 1967; 3():302-8. PubMed ID: 4314430
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of Bordetella strains used in the production of anti-pertussis vaccine in stationary culture].
    Castillejos Carmona R; González Pacheco M
    Salud Publica Mex; 1981; 23(6):549-53. PubMed ID: 6278653
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative study of HBP-2 and FGP-1 culture media in the production of Bordetella pertussis by fermentation].
    Medina García A; Martín Escobar TA; Reyes ET
    Salud Publica Mex; 1981; 23(6):575-84. PubMed ID: 6278656
    [No Abstract]   [Full Text] [Related]  

  • 5. [Development of a fermentation process in the production of pertussis vaccine].
    Recamier L; Medina A; Rodríguez H
    Salud Publica Mex; 1981; 23(6):563-73. PubMed ID: 6278655
    [No Abstract]   [Full Text] [Related]  

  • 6. Variation in Bordetella pertussis.
    Cameron J
    J Pathol Bacteriol; 1967 Oct; 94(2):367-74. PubMed ID: 4294462
    [No Abstract]   [Full Text] [Related]  

  • 7. Areexamination of phase IV Bordetella pertussis.
    Aprile MA
    Can J Microbiol; 1972 Dec; 18(12):1793-801. PubMed ID: 4346447
    [No Abstract]   [Full Text] [Related]  

  • 8. Large-scale production of pertussis vaccine by serial subculture technic.
    Csizér Z; Joó I
    Zentralbl Bakteriol Orig A; 1972 Jul; 221(1):59-64. PubMed ID: 4145107
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bordetella pertussis spheroplasts. 4. The protective, histamine-sensitizing and toxic action of spheroplasts and spheroplast cell walls].
    Milleck J; Ocklitz HW
    Zentralbl Bakteriol Orig A; 1972 Mar; 219(3):358-65. PubMed ID: 4122376
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation between optical density and viable germ count during cultivation of B. pertussis.
    Csizér Z; Pusztai Z; Joó I
    Zentralbl Bakteriol Orig; 1971; 216(2):215-8. PubMed ID: 4325114
    [No Abstract]   [Full Text] [Related]  

  • 11. Study on toxicity of Bordetella pertussis cultures and antigens.
    Spasojević V
    Dev Biol Stand; 1977; 34():197-205. PubMed ID: 190070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of the potency of the pertussis component in DPT vaccine produced in stationary culture and by fermentation].
    Galicia O; Villalva H; Pérez A; Pérez S; Medina A
    Salud Publica Mex; 1981; 23(6):607-11. PubMed ID: 6278658
    [No Abstract]   [Full Text] [Related]  

  • 13. [A comparative analysis of the effect of Bordetella pertussis preparations on a primary culture of murine peritoneal macrophages].
    Tiukavkina SIu; Moskalenko EP
    Mikrobiol Z; 1996; 58(2):58-63. PubMed ID: 8983523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of Bordetella pertussis in the Ribi cell fractionator. 1. Effect of different pressures.
    Hollinger E; Wardlaw AC
    Can J Microbiol; 1971 Sep; 17(9):1169-74. PubMed ID: 4329814
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of pertussis serological potency test. Serological assessment of antibody response induced by whole cell vaccine as an alternative to mouse protection in an intracerebral challenge model.
    van der Ark A; van Straaten-van de Kappelle I; Akkermans A; Hendriksen C; van de Donk H
    Biologicals; 1994 Sep; 22(3):233-42. PubMed ID: 7811457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective activities of "Bordetella pertussis" Tn5 mutants in mice.
    Olander RM; Muotiala A; Parviainen T; Runeberg-Nyman K
    Ann Sclavo Collana Monogr; 1986; 3(1-2):329-35. PubMed ID: 2892513
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunologic reaction of Bordetella pertussis and leukocytic reaction in mice].
    Walecki H; Sitek K
    Med Dosw Mikrobiol; 1966; 18(2):111-5. PubMed ID: 4287625
    [No Abstract]   [Full Text] [Related]  

  • 18. The amino acid utilization by phase 1 Bordetella pertussis in a chemically defined medium.
    Goldner M; Jakus CM; Rhodes HK; Wilson RJ
    J Gen Microbiol; 1966 Sep; 44(3):439-44. PubMed ID: 4291280
    [No Abstract]   [Full Text] [Related]  

  • 19. [Serologic controls of anti-pertussis vaccination].
    Mynard MC; Aymé G; Triau R
    Rev Immunol Ther Antimicrob; 1969; 33(1):7-20. PubMed ID: 4181401
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative analysis of a Bordetella pertussis patient isolated strain and classical strains used in the pertussis vaccine.
    Pereira A; Pereira AS; Moreira-Filho CA; Bando SY; Tambourgi DV
    Vaccine; 2005 Jul; 23(34):4353-8. PubMed ID: 16005744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.